Risedronate prevents hip fractures, but who should get therapy?

Chad L. Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic

Address: Chad L. Deal, MD, Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation,9500 Euclid Avenue, Cleveland, OH 44195

Chad L. Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic

Address: Chad L. Deal, MD, Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation,9500 Euclid Avenue, Cleveland, OH 44195

Chad L. Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic

Address: Chad L. Deal, MD, Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation,9500 Euclid Avenue, Cleveland, OH 44195